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Prevascularization of collagen-
glycosaminoglycan scaffolds: stromal
vascular fraction versus adipose tissue-
derived microvascular fragments
Thomas Später1, Florian S. Frueh2, Ruth M. Nickels1, Michael D. Menger1 and Matthias W. Laschke1*
Abstract
Background: The seeding of scaffolds with the stromal vascular fraction (SVF) of adipose tissue is a common
prevascularization strategy in tissue engineering. Alternatively, adipose tissue-derived microvascular fragments (ad-MVF)
may serve as vascularization units. In contrast to SVF single cells, they represent a mixture of intact arteriolar, capillary
and venular vessel segments. Therefore, we herein hypothesized that the ad-MVF-based prevascularization of scaffolds
is superior to the conventional SVF single cells-based approach.
Results: SVF single cells and ad-MVF were enzymatically isolated from epididymal fat pads of green fluorescent protein
(GFP)+ donor mice to assess their viability and cellular composition using fluorescence microscopy and flow cytometry.
Moreover, collagen-glycosaminoglycan matrices (Integra®) were seeded with identical amounts of the isolates and
implanted into full-thickness skin defects within dorsal skinfold chambers of GFP− recipient mice for the intravital
fluorescent microscopic, histological and immunohistochemical analysis of implant vascularization and incorporation
throughout an observation period of 2 weeks. Non-seeded matrices served as controls. While both isolates contained a
comparable fraction of endothelial cells, perivascular cells, adipocytes and stem cells, ad-MVF exhibited a significantly
higher viability. After in vivo implantation, the vascularization of ad-MVF-seeded scaffolds was improved when compared
to SVF-seeded ones, as indicated by a significantly higher functional microvessel density. This was associated with an
enhanced cellular infiltration, collagen content and density of CD31+/GFP+ microvessels particularly in the center of the
implants, demonstrating a better incorporation into the surrounding host tissue. In contrast, non-seeded matrices
exhibited a poor vascularization, incorporation and epithelialization over time.
Conclusions: The present study demonstrates that ad-MVF are highly potent vascularization units that markedly
accelerate and improve scaffold vascularization when compared to the SVF.
Keywords: Tissue engineering, Stromal vascular fraction, Microvascular fragments, Integra®, Vascularization,
Angiogenesis, Stem cells, Dorsal skinfold chamber
Background
Tissue engineering is an interdisciplinary field of bio-
medical research focusing on the restoration of tissue
defects or even on the replacement of complete organs
[1–3]. A well-established approach for the generation of
tissue constructs is the seeding of cells onto different
biomaterials, which serve as three-dimensional scaffolds.
To ideally promote the function and regenerative cap-
acity of seeded cells, scaffolds should mimic the natural
extracellular matrix [4–7]. Moreover, they should rapidly
vascularize to ensure a sufficient oxygen supply and,
thus, cellular survival [8–10]. To achieve this, prevascu-
larization, i.e. the creation of preformed microvascular
networks in scaffolds prior to their implantation, has
emerged as a promising concept [11].* Correspondence: matthias.laschke@uks.eu1Institute for Clinical & Experimental Surgery, Saarland University, 66421
Homburg/Saar, Germany
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A common prevascularization strategy is the seeding
of vessel-forming cells, such as endothelial cells or stem
cells, onto scaffolds [12, 13]. However, blood vessels do
not only consist of one specific cell type but exhibit a
complex composition with an inner endothelial lining
and surrounding vessel wall-stabilizing cell layers. Taking
this into account, the stromal vascular fraction (SVF) of
adipose tissue is frequently used to induce the formation
of microvascular networks [10, 14]. The SVF results
from the enzymatic digestion of fat samples and is a
mixture of endothelial cells, pericytes, smooth muscle
cells and stem cells [10, 14–16].
Due to its abundance and minimal-invasive accessibility,
adipose tissue is not only an attractive source for the isola-
tion of the SVF [17] but also for the harvesting of adipose
tissue-derived microvascular fragments (ad-MVF) [18].
Digestion of adipose tissue for 45–60 min exclusively
results in SVF single cells [19, 20], whereas a shorter
digestion time of only 10 min provides a mixture of single
cells and ad-MVF [21]. These ad-MVF still represent
intact vessel segments and, thus, exhibit the unique feature
of rapidly reassembling into new microvascular networks
after transplantation [18]. Therefore, we herein hypothe-
sized that the ad-MVF-based prevascularization of scaffolds
is superior to the conventional SVF-based approach.
To test our hypothesis, we isolated both SVF single cells
and ad-MVF from epididymal fat pads of donor mice
according to well-established protocols. Subsequently,
comparable amounts of the isolates were seeded onto
collagen-glycosaminoglycan matrices. The seeded scaffolds
were then implanted into full-thickness skin defects within
mouse dorsal skinfold chambers for the in vivo analysis
of implant vascularization and incorporation throughout
an observation period of 2 weeks. Non-seeded matrices
served as controls.
Results
Viability, cellular composition and activity of SVF single
cells and ad-MVF
SVF single cells and ad-MVF were isolated from the
bilateral epididymal fat pads of transgenic green fluor-
escent protein (GFP)+ C57BL/6 mice (Fig. 1a-c). This
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Fig. 1 SVF and ad-MVF isolation and scaffold seeding. a Epididymal
fat pads (arrows) of a GFP+ C57BL/6 donor mouse. Scale bar: 10 mm. b,
c Freshly isolated SVF single cells (b) and ad-MVF (c). Scale bars: 50 μm.
d, e Fluorescence microscopy of bisbenzimide (blue)/propidium iodide
(red)-stained SVF single cells (d) and ad-MVF-associated cells (e) for the
assessment of viability (arrows = dead propidium iodide+ cells). Scale
bars: 50 μm. f Integra® scaffold on the tip of a micro forceps directly
after sample preparation. Scale bar: 2.4 mm. g, h Scheme displaying
scaffold seeding with SVF single cells (blue) (g) and ad-MVF (red) (h). i
Overview of the dorsal skinfold chamber window directly after
implantation of an Integra® scaffold (black frames = ROIs in the border;
white frames = ROIs in the center). Scale bar: 1.8 mm
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allowed the identification of both isolates after transplant-
ation into GFP− recipient animals. To analyze the viability of
freshly isolated SVF single cells and ad-MVF, bisbenzimide/
propidium iodide staining was performed to assess the
percentage of propidium iodide+ dead cells in relation
to all counted cells by means of fluorescence microscopy
(Fig. 1d and e). This analysis revealed a viability of 82 ± 1%
in the group of SVF single cells. In contrast, ad-MVF
exhibited a significantly higher viability of 95 ± 1%.
Additional flow cytometric analyses showed a comparable
cellular composition of SVF single cells and ad-MVF
(Table 1). They contained a mixture of CD31+ endothelial
cells, α-smooth muscle actin (SMA)+ perivascular cells,
adipocyte-specific adhesion molecule (ASAM)+ adipocytes
as well as cells positive for the stromal/stem cell surface
markers CD29, CD90 and CD117 (Table 1). To further
assess the activity of isolated SVF single cells and ad-MVF
in vitro, both isolates were cultivated over 6 days and
analyzed by means of a water-soluble tetrazolium (WST)-1
assay directly after isolation as well as on day 3 and 6. The
cellular activity of both isolates was comparable directly
after isolation (absorbance 450 nm: 0.05 ± 0.02 (SVF) vs.
0.07 ± 0.03 (ad-MVF); p > 0.05) and progressively increased
over time. Of interest, this increase was much more
pronounced in the group of ad-MVF (absorbance 450 nm:
0.46 ± 0.15 (d3) and 1.18 ± 0.29 (d6)) when compared to
SVF single cells (absorbance 450 nm: 0.06 ± 0.01 (d3) and
0.10 ± 0.02 (d6); p < 0.05).
Seeding of scaffolds
As scaffold material we used Integra® dermal regeneration
template single layer without silicone sheet (Fig. 1f), which
is a ready-to-use porous off-the-shelf sheet matrix that
consists of cross-linked bovine tendon collagen and shark
glycosaminoglycan [22, 23]. To guarantee an equivalent
overall number of cells per scaffold in both experimental
groups, SVF single cells and ad-MVF were isolated from
an identical volume of 250 μL adipose tissue. Quantitative
analyses revealed that this volume corresponded to
either ~ 1,000,000 SVF single cells or ~ 10,000 ad-MVF.
Noteworthy, the ad-MVF isolates additionally contained
~ 200,000 single cells and, thus, have to be considered as a
mixture of vessel segments and cells. For the seeding of
the scaffolds (Figs 1g and h), the isolates were resuspended
in 10 μL 0.9% NaCl. Importantly, the scaffold material
absorbed the entire volume of both suspensions preventing
the loss of individual cells and ad-MVF during the seeding
procedure.
Histological analyses were performed to analyze the
cell distribution within freshly seeded scaffolds. For this
purpose, the number of cells was counted in 9 regions of
interest (ROIs) per implant (equivalent to the entire
implant area per section) to calculate the coefficient of
variation (cv; standard deviation / mean) of the spatial cell
distribution. Because ad-MVF were mainly trapped on the
implants’ surface and SVF single cells were able to pene-
trate deeper into the pores of the scaffolds (Additional file 1:
Figure S1a and b), the cv was significantly higher in the
group of ad-MVF-seeded scaffolds when compared to
SVF-seeded matrices (Additional file 1: Figure S1c).
Vascularization of seeded scaffolds
According to Sorg et al. [24, 25], a modified mouse dorsal
skinfold chamber model was used to repetitively analyze
the in vivo vascularization of SVF- and ad-MVF-seeded
scaffolds by means of intravital fluorescence microscopy.
The vascularization of the implanted scaffolds was
assessed in 4 ROIs in their center and in 4 ROIs in their
border zones (Fig. 1i). Functionality of individual micro-
vessels was proven by their perfusion with the plasma
marker fluorescein isothiocyanate (FITC)-labeled dextran
(Fig. 2a-f). In both groups, the first blood-perfused micro-
vessels could be detected in the border and center zones
of the implants on day 6 (Fig. 2g-j). Throughout the
following observation period, the density of these micro-
vessels progressively increased (Fig. 2i and j). Notably,
ad-MVF-seeded implants exhibited a significantly higher
fraction of perfused ROIs and a higher functional micro-
vessel density (FMD) in their border zones when com-
pared to SVF-seeded scaffolds on day 14 after implantation
(Fig. 2g and i). This difference in vascularization was even
more pronounced in the center of the implants. Whereas
ad-MVF-seeded scaffolds were completely vascularized on
day 14 (corresponding to 100% perfused ROIs), the frac-
tion of perfused ROIs was only 25% in the group of
SVF-seeded implants (Fig. 2h). In addition, the FMD of
ad-MVF-seeded scaffolds was also 3.4-fold higher at this
time point (Fig. 2j).
The additional measurement of microhemodynamic
parameters revealed that the diameter of individual
microvessels within the border and center zones of the
implants decreased in both groups over time (Table 2).
Table 1 Cellular expression (%) of CD31, α-SMA, ASAM, CD29, CD90 and CD117 in the SVF and ad-MVF isolated from 1 mL
epididymal fat pads of GFP+ donor mice (n = 3 per group), as assessed by flow cytometric analysis
CD31 α-SMA ASAM CD29 CD90 CD117
SVF 26.4 ± 3.3 17.3 ± 1.2 14.4 ± 3.2 47.6 ± 4.7 10.4 ± 3.3 12.7 ± 3.3
Ad-MVF 18.0 ± 3.2 16.4 ± 2.3 13.0 ± 1.6 47.5 ± 4.7 7.1 ± 2.3 9.2 ± 1.7
Means ± SEM
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This was associated with an increase of the centerline red
blood cell (RBC) velocity and wall shear rate (Table 2).
There were no significant differences of microhemody-
namics within individual microvessels between SVF- and
ad-MVF-seeded scaffolds throughout the 14-day observa-
tion period.
As previously reported [26, 27], the vascularization of
ad-MVF-seeded implants induces hemorrhagic bleeding,
which is most pronounced between day 6 and 10 of
microvascular network formation. These findings were
confirmed in the present study (Fig. 3a-g). The assessment
of a hemorrhagic score showed no significant differences
between SVF- and ad-MVF-seeded implants (Fig. 3g).
Incorporation of SVF- and ad-MVF-seeded scaffolds
On day 14 after implantation, SVF- and ad-MVF-seeded
scaffolds were additionally analyzed by means of histology
and immunohistochemistry. The analysis of hematoxylin
and eosin (HE)-stained sections showed a comparable
infiltration of a dense granulation tissue at the border zones
of SVF- (3697 ± 373 cells/mm2) and ad-MVF-seeded
(4515 ± 347 cells/mm2) implants (Fig. 4a and c). In contrast,
e
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Fig. 2 Intravital fluorescence microscopy of implanted scaffolds. a-f Intravital fluorescence microscopy (blue light epi-illumination with contrast
enhancement by 5% FITC-labeled dextran) of SVF- (a-c) and ad-MVF-seeded (d-f) Integra® scaffolds on day 14 after implantation into full-thickness skin
defects within dorsal skinfold chambers of C57BL/6 recipient mice (dotted lines = implant borders; arrows = perfused blood vessels; b, e = higher
magnifications of inserts in a and d; c, f = higher magnifications of inserts in b and e). Scale bars: a, d = 2.4 mm; b, e = 500 μm; c, f = 125 μm. g-j
Perfused ROIs (g, h) and FMD (i, j) in the border (g, i) and center zones (h, j) of SVF- (white circles, n = 8) and ad-MVF-seeded (black circles, n = 8)
Integra® scaffolds on day 0, 3, 6, 10 and 14 after implantation, as assessed by intravital fluorescence microscopy. Means ± SEM. *p < 0.05 vs. SVF-seeded
Integra® scaffolds
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ad-MVF-seeded scaffolds exhibited a significantly higher
number of infiltrating cells in their center zones (3465 ±
433 cells/mm2) when compared to SVF-seeded scaffolds
(1884 ± 485 cells/mm2; p < 0.05) (Fig. 4b and d). Although
not proven to be significant, further quantitative analyses of
Sirius red-stained sections revealed that SVF-seeded
implants contained less collagen fibers within their
center zones when compared to ad-MVF-seeded scaffolds
(Fig. 4e-h). Taken together, these results indicate an accel-
erated cellular infiltration and matrix formation in the
center of ad-MVF-seeded scaffolds and, thus, an improved
incorporation of the implants at the end of the 14-day
observation period.
In line with our intravital fluorescent microscopic find-
ings, additional immunohistochemical analyses showed a
significantly higher density of CD31+ microvessels in both
the border and center zones of ad-MVF-seeded scaffolds
when compared to SVF-seeded implants (Fig. 4i-m).
CD31+/GFP+ co-stainings further revealed that > 90%
of all microvessels in the center zones of both implant
types originated from the seeded GFP+ SVF or ad-MVF,
respectively (Fig. 4n-q). However, whereas the border
zones of ad-MVF-seeded scaffolds contained a compar-
ably high fraction of GFP+ microvessels, the SVF-seeded
implants exhibited a significantly reduced fraction of only
67% (Fig. 4q).
Epithelialization of SVF- and ad-MVF-seeded scaffolds
The observation window of the dorsal skinfold chamber
further allowed the repetitive stereomicroscopic analysis
of implant epithelialization (Fig. 5a-f ). Both SVF- and
ad-MVF-seeded scaffolds exhibited a comparable epithe-
lialization throughout the 14-day observation period
(Fig. 5g). These results were confirmed by additional
immunohistochemical analyses on day 14, which revealed
that ~ 80% of SVF- and ad-MVF-seeded implants were
covered with a cytokeratine+ epithelial layer (Fig. 5h-j).
Vascularization, incorporation and epithelialization of
non-seeded scaffolds
Although it was not the primary aim of the present
study to compare seeded vs. non-seeded scaffolds, we
additionally analyzed non-seeded Integra® matrices in
the dorsal skinfold chamber model. By this, we could
demonstrate that the vascularization, incorporation and
epithelialization of SVF- and ad-MVF-seeded scaffolds
were not markedly influenced by the implanted biomaterial
itself. In fact, repetitive intravital fluorescence microscopy
revealed a poor vascularization with < 15% perfused ROIs
and a FMD of < 2 cm/cm2 in the implants’ border zones
(Additional file 2: Figure S2a-c, d and f). The center of the
scaffolds even remained avascular throughout the entire
Table 2 Diameter, centerline RBC velocity and wall shear rate of
individual microvessels within SVF- and ad-MVF-seeded Integra®
matrices directly (0d) as well as 3, 6, 10 and 14 days after
implantation into dorsal skinfold chambers
0d 3d 6d 10d 14d
Diameter [μm]:
SVF border – – 32.0 ± 2.6 18.3 ± 1.6 17.6 ± 1.4
ad-MVF border – – 27.4 ± 3.6 19.2 ± 0.8 17.6 ± 1.9
SVF center – – 30.6 ± 1.3 23.1 ± 2.9 15.7 ± 1.4
ad-MVF center – – 21.9 ± 9.9 22.8 ± 1.2 20.4 ± 3.2
Centerline RBC velocity [μm/s]:
SVF border – – 299.8 ± 102.8 307.8 ± 71.7 657.7 ± 158.2
ad-MVF border – – 117.6 ± 47.3 284.7 ± 102.7 311.9 ± 51.8
SVF center – – 133.1 ± 84.1 388.2 ± 67.7 483.7 ± 82.0
ad-MVF center – – 182.3 ± 121.3 332.9 ± 113.5 309.8 ± 26.2
Wall shear rate [s− 1]:
SVF border – – 75.2 ± 23.3 125.1 ± 20.3 291.8 ± 45.8
ad-MVF border – – 33.1 ± 11.9 116.8 ± 31.6 150.7 ± 31.9
SVF center – – 35.9 ± 23.6 145.9 ± 33.2 245.7 ± 55.5
ad-MVF center – – 58.5 ± 17.8 121.3 ± 44.6 130.5 ± 28.9
Means ± SEM
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Fig. 3 Implant-induced hemorrhage formation. a-f Transillumination
stereomicroscopy of implanted ad-MVF-seeded Integra® scaffolds
within dorsal skinfold chambers of C57BL/6 mice. The implants
exhibit different degrees of implant-induced bleedings (% of total
surface area) according to the semi-quantitative hemorrhagic score,
i.e. 1: no bleeding (a), 2: 1–25% (b), 3: 26–50% (c), 4: 51–75% (d), 6:
76–100% (e), 6: bleeding exceeding implant surface (f). Scale bars:
2.3 mm. g Hemorrhagic score of SVF- (white circles, n = 8) and
ad-MVF-seeded (black circles, n = 8) Integra® scaffolds on day 0, 3, 6,
10 and 14 after implantation, as assessed by stereomicroscopy.
Means ± SEM
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Fig. 4 (See legend on next page.)
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observation period (Additional file 2: Figure S2e and g).
Additional histological analyses showed a poor cellular
infiltration (border: 1817 ± 162 cell/mm2; center: 698 ±
43 cells/mm2) and collagen content of the implants on
day 14 (Additional file 3: Figure S3a-c). The immunohisto-
chemical detection of CD31+ microvessels further demon-
strated a low microvessel density in the border and center
zones of the non-seeded scaffolds (Additional file 3:
Figure S3d). This was associated with a weak epithelializa-
tion (< 35%) of the implants’ surface on day 14 (Additional
file 3: Figure S3e).
Discussion
During the last two decades, a rapidly increasing number
of studies have indicated a high vascularization potential
of the SVF for applications in the field of tissue engineering
and regenerative medicine [15, 28]. This heterogeneous cell
isolate can easily be harvested from adipose tissue by
enzymatic digestion without any complex cell separation or
cultivation steps, which makes it an ideal candidate for au-
tologous intra-operative one-step procedures. Accordingly,
several automated and semi-automated SVF-isolating
systems are already available for clinical use [29–32]. Of
interest, others and we have shown that adipose tissue can
also serve as a rich source for the isolation of intact and
fully functional vessel segments when using a reduced
enzymatic digestion time [21, 33]. These so-called ad-MVF
rapidly reassemble into new microvascular networks after
transplantation [34]. Importantly, our novel results now
demonstrate that, due to this unique property, the seeding
of scaffolds with ad-MVF markedly accelerates and
improves vascularization after implantation when compared
to the seeding with SVF.
In the present proof-of-principle study, we used the
collagen-glycosaminoglycan matrix Integra®, which is a
clinically well-established dermal substitute for the
coverage of full-thickness skin defects. Beyond, Integra®
is frequently used as scaffold material for experimental
tissue engineering studies, because it easily enables cellular
seeding due to its porous structure with pore sizes ranging
between 20 and 125 μm [35]. In a previous study, we could
show that a rapid and sufficient vascularization of
12.5 mm2 Integra® is achieved by a minimum seeding
density of ~ 10,000 ad-MVF and 200,000 single cells,
which can be isolated from 250 μL adipose tissue
within a short enzymatic digestion time of 10 min [26].
The identical amount of adipose tissue was herein used
for the generation of the SVF to ensure an identical cell
load per scaffold, and, thus to guarantee a standardized
comparison of the vascularization potential between
the SVF and ad-MVF. For the complete disassembly of
adipose tissue into the SVF a longer enzymatic digestion
time was required. The longer exposure to collagenase
may also explain the significantly reduced cell viability of
the SVF when compared to ad-MVF. Noteworthy, our
results are in line with previous studies reporting a SVF
viability ranging between 80 and 83% [30, 36]. In addition,
we detected a markedly higher cellular activity of ad-MVF
on day 3 and 6 after isolation as a possible consequence of
their improved viability. Moreover, the multi-cellular and
three-dimensional architecture of ad-MVF may have
further contributed to their higher cellular activity, as
already described for cell spheroids [37]. This view is
also supported by the observation that the vascularization
of scaffolds is improved after their seeding with three-
dimensional spheroids when compared to single cells [38].
All commercially available systems for the separation of
the SVF from lipoaspirates exhibit a great heterogeneity in
the outcome of the isolates’ cellular composition [30].
Along with this finding, our flow cytometric analyses
revealed that the SVF and ad-MVF are a mixture of endo-
thelial cells, perivascular cells, adipocytes and stem cells.
Although this heterogeneous composition may complicate
the standardization of the method for a broad clinical
application, it also bears several major advantages. In fact,
unlike purified cell preparations, the isolation of the
SVF and ad-MVF is not associated with any complex
cell separation or manipulative cultivation steps. This
may facilitate the fulfilment of regulatory criteria for
clinical approval. In addition, the mixture of different
cell types may markedly contribute to an improved
vascularization and tissue regeneration. In line with this
(See figure on previous page.)
Fig. 4 Incorporation and vascularization of implanted scaffolds. a-d HE-stained sections of SVF- (a, b) and ad-MVF-seeded (c, d) Integra® scaffolds
on day 14 after implantation into full-thickness skin defects within dorsal skinfold chambers of C57BL/6 recipient mice (broken lines = implant; closed
frames = center zones of the implants; b, d= higher magnifications of closed frames in a and c arrows = nuclei of individual cells). Scale bars: a, c= 260 μm;
b, d= 40 μm. e-g Polarized light microscopy of Sirius red-stained sections of normal skin (e) as well as SVF- (f) and ad-MVF-seeded (g) Integra® scaffolds.
Scale bars: 25 μm. h Total collagen ratio in the border and center zones of SVF- (white bars, n= 8) and ad-MVF-seeded (black bars, n= 8) Integra® scaffolds
on day 14 after implantation, as assessed by histology. Means ± SEM. i-l Immunohistochemical detection of CD31+ microvessels (arrows) within the border
(i, j) and center (k, l) zones of SVF- (i, k) and ad-MVF-seeded (j, l) Integra® scaffolds. Scale bars: 25 μm. m Microvessel density in the border and center zones
of SVF- (white bars, n= 8) and ad-MVF-seeded (black bars, n= 8) Integra® scaffolds on day 14 after implantation, as assessed by immunohistochemistry.
Means ± SEM. *p< 0.05 vs. SVF-seeded Integra® scaffolds. n-p Representative immunohistochemical staining of CD31+/GFP+ microvessels (arrows) and
CD31+/GFP− microvessels (arrowheads) within the border zone of a SVF-seeded Integra® scaffold on day 14 after implantation. Scale bars:
55 μm. q CD31+/GFP+ microvessels in the border and center zones of SVF- (white bars, n = 8) and ad-MVF-seeded (black bars, n = 8) Integra®
scaffolds on day 14 after implantation, as assessed by immunohistochemistry. Means ± SEM. *p < 0.05 vs. SVF-seeded Integra® scaffolds
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view, animal studies reported a better therapeutic out-
come in the treatment of acute myocardial infarction or
nerve injury when transplanting the SVF in comparison
to purified adipose-derived stem cells [39, 40].
For the in vivo analysis of vascularization and incorp-
oration, we implanted non-seeded as well as SVF- and
ad-MVF-seeded Integra® matrices into full-thickness skin
defects within modified dorsal skinfold chambers. In
combination with intravital fluorescence microscopy, this
approach not only allowed us to detect newly formed
microvessels within the implants, but also to prove their
functionality and to assess microhemodynamic parameters
by the direct visualization of blood perfusion. Of note, we
found that non-seeded scaffolds only exhibited a poor
vascularization and incorporation, indicating that the im-
planted biomaterial itself did not induce a strong host tissue
response, as already shown in previous studies [41, 42].
In both SVF- and ad-MVF-seeded scaffolds, first blood-
perfused microvessels could be found on day 6. At this
time point, we also detected increased hemorrhage forma-
tion, which was most probably caused by an increased
leakage of blood. As a typical sign of microvascular
remodeling, microvessel diameters decreased while their
centerline RBC velocities and wall shear rates increased
throughout the further observation period. Although these
characteristics of implant vascularization did not differ
between the two groups, ad-MVF-seeded matrices
exhibited a significantly higher number of perfused
ROIs and a higher FMD in their border and center
zones when compared to SVF-seeded implants. This
can be explained by the fact that ad-MVF already repre-
sent fully functional arteriolar, capillary and venular
segments that develop interconnections with each other
and the surrounding microvasculature of the host tissue
via the process of inosculation to establish a rapid
blood perfusion within the implants [41]. In contrast,
Koh et al. [43] showed that the endothelial cells within
SVF suspensions first reassemble into new vessel chan-
nels as a precondition for the subsequent formation of
microvascular networks. Hence, the time needed to
complete this process is much longer when compared
to ad-MVF-based vascularization. In this context, it
a b c
d
g
h
i
j
e f
Fig. 5 Epithelialization of implanted scaffolds. a-f Stereomicroscopic
images showing the epithelialization of implanted SVF- (a-c) and
ad-MVF-seeded (d-f) Integra® scaffolds directly (a, d) as well as on
day 6 (b, e) and 14 (c, f) after implantation. Scale bars: 1 mm. g
Epithelialization of SVF- (white bars, n = 8) and ad-MVF-seeded (black
bars, n= 8) Integra® scaffolds on day 0, 3, 6, 10 and 14 after implantation,
as assessed by trans-illumination microscopy. Means ± SEM. h, i
Immunohistochemical detection of the cytokeratine+ epithelial layer
(arrows) covering SVF- (h) and ad-MVF-seeded (i) Integra® scaffolds. Scale
bars: 300 μm. j Epithelialization of SVF- (white bars, n= 8) and ad-MVF-
seeded (black bars, n= 8) Integra® scaffolds on day 14 after implantation,
as assessed by immunohistochemistry. Means ± SEM
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should also be noted that ad-MVF exhibit a length up to
150 μm [26], preventing their homogeneous distribution
within implants. On the other hand, a locally limited high
density of rather large ad-MVF may facilitate the direct
bridging of rather wide distances within tissue constructs
in a short period. Accordingly, ad-MVF promote a more
homogeneous blood perfusion within the border and cen-
ter zones of implanted tissue constructs. In line with this
view, the difference in vascularization between the SVF
and ad-MVF group was most pronounced in the center of
the implants, where > 90% of all detected microvessels
originated from the seeded GFP+ SVF or ad-MVF.
Hypoxia-driven release of pro-angiogenic growth factors
from the seeded cells may have additionally stimulated the
angiogenic ingrowth of GFP− microvessels from the
surrounding host tissue. The physiological growth rate of
microvessels is estimated not to be faster than ~ 5 μm/h
[44]. Hence, such host vessels are mainly expected to
occur in the border zones of the implants. In these
regions, SVF- and ad-MVF-seeded scaffolds contained
a fraction of ~ 30% and ~ 10% GFP− microvessels,
respectively. Taking into account that the microvessel
density of ad-MVF-seeded scaffolds was ~ 3-fold higher,
these immunohistochemical findings demonstrate a
comparable number of ingrowing GFP− microvessels from
the surrounding host tissue into both implant types.
A sufficient vascularization represents a major pre-
requisite for an adequate implant incorporation [45, 46].
Accordingly, we herein observed an accelerated cellular
infiltration and collagen formation in the center of
ad-MVF-seeded Integra® matrices when compared to
SVF-seeded ones. However, against our expectations, we
did not detect any differences in implant epithelialization
between the two groups. This may be due to the fact
that both SVF- and ad-MVF-seeded matrices initially
contained an identical cellular composition and load.
Hence, they may have also released identical growth factor
concentrations stimulating a vascularization-independent
coverage with ingrowing keratinocytes from the wound
edges.
Conclusions
The present study demonstrates several important
advantages of ad-MVF for the prevascularization of
scaffolds when compared to the SVF. The faster isolation
of ad-MVF may allow their application in a less time-
consuming intra-operative procedure. Moreover, they
exhibit a higher viability due the shorter enzymatic diges-
tion time, which may markedly contribute to enhance cell
yield and, thus, to reduce the volume of adipose tissue
needed for individual patient treatments. Finally, ad-MVF
are fully functional vessel segments that markedly
accelerate and improve the vascularization of scaffolds.
Taken together, all these unique features of ad-MVF
suggest their future clinical use as vascularization units
in tissue engineering.
Methods
Animals
Dorsal skinfold chambers were implanted in C57BL/6
wild-type mice (Institute for Clinical & Experimental
Surgery, Saarland University, Homburg, Germany) with
an age of 3–6 months and a body weight of 24–30 g.
Epididymal fat was isolated from transgenic GFP+ mice
(C57BL/6-Tg(CAG-EGFP)1Osb/J; The Jackson Laboratory,
Bar Harbor, ME, USA) with an age of 7–12 months and a
body weight of > 30 g. The animals were housed under a
12 h day/night cycle and fed with water and standard pellet
food (Altromin, Lage, Germany) ad libitum.
Isolation of SVF single cells and ad-MVF
For the isolation of ad-MVF, the fat pads were washed
thrice in phosphate-buffered saline (PBS) before mechanical
dissection. Subsequently, the minced adipose tissue was
enzymatically digested with collagenase NB4G (0.5 U/mL;
Serva, Heidelberg, Germany) under slow stirring and
humidified atmospheric conditions (37 °C, 5% CO2) for
10 min. The digestion was neutralized with PBS supple-
mented with 20% fetal calf serum (FCS). Then, the
cell-vessel suspension was incubated at 37 °C for 5 min
and the fat supernatant was removed. The remaining
suspension was filtered through a 500 μm mesh and a
mixture of GFP+ ad-MVF and single cells was enriched
to a final pellet by 5 min centrifugation at 120 x g.
For the isolation of SVF single cells, the bilateral fat
pads from GFP+ C57BL/6 mice were harvested and
mechanically minced as described above. The fat tissue
was also enzymatically digested with collagenase NB4G
(0.5 U/mL) under atmospheric conditions, however, for
a longer time period of 60 min. To remove remaining
fat clots, the suspension was then filtered through a
40 μm mesh and GFP+ single cells were subsequently
enriched to a final pellet by a 5 min centrifugation at
120 x g.
Viability of SVF single cells and ad-MVF
The final pellets of either SVF single cells or ad-MVF were
resuspended in 1 mL PBS containing 2 mg/mL bisbenzi-
mide and 1 mg/mL propidium iodide. Subsequently, 10 μL
of these suspensions were transferred in a petri dish and
analyzed by means of fluorescence microscopy. The ana-
lyses were performed in 10 randomly selected ROIs, each
containing ~ 100 SVF single cells or ad-MVF cells.
Flow cytometry
For flow cytometric analyses, isolated SVF single cells and
ad-MVF, which were digested in Accutase® (BioLegend,
Fell, Germany) for 30 min into single cells, were used. The
Später et al. Journal of Biological Engineering           (2018) 12:24 Page 9 of 13
single cells were analyzed for the expression of the
monoclonal rat anti-mouse endothelial cell marker
CD31-phycoerythrin (PE) (BD Biosciences, Heidelberg,
Germany), the perivascular cell marker mouse anti-α-
SMA (Thermo Fisher Scientific Inc., Waltham, MA,
USA) and the monoclonal stromal/stem cell surface
markers rat anti-mouse CD117-FITC (BD Biosciences),
mouse anti-rat/mouse CD90-FITC (BioLegend) and
hamster-anti-mouse CD29-FITC (BioLegend). Isotype
identical rat IgG-PE or rat IgG-FITC (BD Biosciences),
mouse IgG-FITC (BD Biosciences) and hamster IgG-
FITC (BioLegend) served as controls. Additionally, cells
were analyzed for the expression of the purified polyclonal
sheep anti-mouse/human adipocyte marker ASAM (R&D
Systems, Wiesbaden, Germany) followed by a secondary
donkey anti-sheep IgG-Alexa488 antibody (Molecular
Probes, Eugene, OR, USA). Flow cytometric analyses
were performed by means of a FACScan (BD Biosciences)
and data were assessed using the software package Cell-
Quest Pro (BD Biosciences).
Activity of SVF single cells and ad-MVF
For the in vitro analysis of cellular activity, final pellets
of either SVF single cells or ad-MVF were cultivated in
96-well plates at 37 °C for 6 days in 100 μL Dulbecco’s
Modified Eagle Medium (DMEM; 10% FCS, 100 U/mL
penicillin, 0.1 mg/mL streptomycin; Biochrom, Berlin,
Germany) under humidified conditions (5% CO2) with a
medium change on day 3. The cellular activity of the
isolates was assessed directly after isolation as well as on
day 3 and 6 by means of a WST-1 assay (Roche diagnostics,
Mannheim, Germany) according to the manufacturer’s
instructions. For this purpose, 10 μL of WST-1 reagent
were added per well and the plate was incubated for
30 min at 37 °C. Using a microplate reader, the absorption
was measured at 450 nm with 620 nm set as a reference
and the data were corrected to blank values.
Seeding of scaffolds
For scaffold preparation, 12.6 mm2 samples were identically
cut out of a 1.3 mm thick Integra® dermal regeneration
template single layer without silicone sheet (Integra Life
Sciences, Ratingen, Germany) with a 4 mm biopsy punch
(kaiEurope GmbH, Solingen, Germany). The scaffolds
were then placed on a 500 μm strainer for the seeding
with ~ 1,000,000 SVF single cells or a mixture of ~ 10,000
ad-MVF and ~ 200,000 single cells, each resuspended in
10 μL 0.9% NaCl.
Modified dorsal skinfold chamber model
Prior to the chamber implantation, the mice were anes-
thetized by an intraperitoneal injection of ketamine
(75 mg/kg body weight; Ursotamin®, Serumwerke Bernburg,
Bernburg, Germany) and xylazine (15 mg/kg body weight;
Rompun®, Bayer, Leverkusen, Germany). As previously
described in detail [47], the two symmetrical titanium
frames of the chamber were then fixed on the extended
dorsal skinfold of the animals. After the mice recovered
for 48 h, a 4 mm full-thickness skin defect was created
within the observation window of each chamber, using
a dermal biopsy punch (kaiEurope GmbH) and microsur-
gical instruments. The defect was filled with a non-seeded,
SVF- or ad-MVF-seeded scaffold and sealed with a remov-
able cover glass.
Stereomicroscopy
To measure both epithelialization and implant-induced
bleeding of the implanted scaffolds by planimetry, the
anesthetized animals were fixed on a Plexiglas® stage and
the dorsal skinfold chambers were positioned under a
stereomicroscope (Leica M651, Wetzlar, Germany) on
day 0 (day of implantation), 3, 6, 10 and 14. Epithelialized
and non-epithelialized implant areas (given in %) were
visualized by epi-illumination and epithelialization was
calculated by the equation: (total implant area – non-
epithelialized implant area) / (total implant area) × 100
[27]. In addition, trans-illumination was used to deter-
mine the extent of implant-induced bleeding (given in %
of implant surface) by means of a semi-quantitative
hemorrhagic score as follows: 1: no bleeding, 2: 1–25%, 3:
26–50%, 4: 51–75%, 5: 76–100%, 6: bleeding exceeding
implant surface. All microscopic images were recorded by
a DVD system and analyzed using the computer-assisted
off-line analysis system CapImage (Zeintl, Heidelberg,
Germany).
Intravital fluorescence microscopy
To achieve a sufficient contrast enhancement for intravital
fluorescence microscopy, 0.1 mL of the blood plasma
marker FITC-labeled dextran (5%; 150,000 Da; Sigma-
Aldrich, Taufkirchen, Germany) was retrobulbarily
injected into the venous plexus of the anesthetized
animals. The observation window of the dorsal skinfold
chamber was then positioned under a Zeiss Axiotech
fluorescent microscope (Zeiss, Oberkochen, Germany)
and the microscopic images were recorded by a charge-
coupled device video camera (FK6990; Pieper, Schwerte,
Germany) and a DVD system for the analysis by means of
the computer-assisted off-line analysis system CapImage.
As previously described [27], the vascularization of the
implanted scaffolds was assessed in 4 ROIs in their center
and in 4 ROIs in their border zones (Fig. 1i). ROIs exhibit-
ing RBC-perfused microvessels were defined as perfused
ROIs (% of all ROIs). In these ROIs the FMD was deter-
mined as the total length of all RBC-perfused microvessels
per ROI (cm/cm2). Additionally, the diameter (d, μm) of
40 randomly selected microvessels was determined by the
length of a measuring line perpendicular to the course of
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the vessels. Moreover, the centerline RBC velocity (v, μm/s)
of the identical microvessels was assessed using the
computer-assisted line-shift-diagram method [48]. These
two parameters were subsequently used to calculate
the wall shear rate (y, s− 1) by means of the Newtonian
definition y = 8 x v/d.
Experimental protocol
In a first set of in vitro experiments, epididymal fat pads
were harvested from 12 GFP+ C57BL/6 donor mice to
analyze the viability, composition and activity of SVF single
cells and ad-MVF by means of fluorescence microscopy,
flow cytometry and WST-1 assays. In a second set of in
vitro experiments, SVF single cells and ad-MVF were har-
vested from 8 GFP+ C57BL/6 donor mice for the histo-
logical analysis of cell distribution within the matrices.
For in vivo analyses, SVF single cells and ad-MVF were
isolated from the adipose tissue of 8 GFP+ C57BL/6 donor
mice and subsequently seeded onto 16 Integra® scaffolds.
The matrices were then implanted into full-thickness skin
defects within dorsal skinfold chambers of 16 C57BL/6
wild-type mice. Vascularization, implant-induced bleeding
and epithelialization of the implants (n = 8 per group) were
analyzed by means of stereomicroscopy and intravital
fluorescence microscopy on day 0 (day of implantation), 3,
6, 10 and 14. Vascularization and epithelialization of
non-seeded Integra® scaffolds were further assessed in the
dorsal skinfold chamber of 4 C57BL/6 wild-type mice.
Thereafter, all animals were sacrificed by means of cervical
dislocation and the dorsal skinfold chamber preparations
were processed for histological and immunohistochemical
analyses.
Histology and immunohistochemistry
Formalin-fixed samples of non-seeded, SVF- and ad-MVF-
seeded implants were embedded in paraffin and cut into
3 μm-thick sections. Individual sections were stained with
HE according to standard procedures. By using a BX60
microscope (Olympus, Hamburg, Germany) and the
imaging software cellCens Dimension 1.11 (Olympus),
the density of infiltrating cells (mm− 2) was assessed in
the border (2 ROIs) and center zones (3 ROIs) of the
implants. In addition, Sirius red-stained sections were used
to analyze the collagen content within the implants in rela-
tion to normal skin, as previously described in detail [41].
Sections were further co-stained with a monoclonal
rat anti-mouse antibody against CD31 (1:100; Dianova,
Hamburg, Germany) and a polyclonal goat antibody
against GFP (1:200; Rockland Immunochemicals, Limerick,
PA, USA), followed by a goat anti-rat IgG Alexa555
antibody (Life Technologies, Ober-Olm, Germany) and a
biotinylated donkey anti-goat antibody (1:30; Dianova) as
secondary antibodies. The biotinylated antibody was de-
tected by streptavidin-Alexa 488 (1:50; Life Technologies)
and cell nuclei were stained with Hoechst 33342 (2 μg/mL;
Sigma-Aldrich). The density of CD31+ microvessels (given
in mm− 2) and the fraction of CD31+/GFP+ microvessels
(given in %) were quantitatively analyzed within the
implants’ border and center zones.
For the immunohistochemical detection of the cytokera-
tine+ epithelial layer covering the implants on day 14, sec-
tions of the largest cross-sectional diameter of the scaffolds
were incubated with a rabbit polyclonal anti-cytokeratine
antibody (1:100; Abcam, Cambridge, UK) as primary anti-
body followed by a biotinylated goat anti-rabbit IgG anti-
body (ready-to-use; Abcam). The biotinylated antibody was
detected by peroxidase-labeled-streptavidin (1:50; Sigma-
Aldrich) and 3,3-diaminobenzidine (Sigma-Aldrich)
was used as chromogen. Using a BZ-8000 microscopic
system (Keyence, Osaka, Japan), the length of the cytokera-
tine+ epithelial layer and the diameter of the implants were
measured to assess epithelialization as: (length of cytokera-
tine+ epithelial layer / total diameter of implant) * 100.
For the in vitro analysis of cell distribution, freshly
SVF- and ad-MVF-seeded scaffolds were embedded in
Tissue-tek® O.C.T. compound (A. Hartenstein GmbH,
Würzburg, Germany), quick-frozen in liquid nitrogen at
− 196 °C and subsequently cut into 3 μm-thick cryosec-
tions. Cell nuclei were stained with Hoechst 33342
(2 μg/mL; Sigma-Aldrich) and the sections were examined
with a BX60 microscope (Olympus). The number of cells
was determined in 9 ROIs per implant (equivalent to the
entire implant area per section) to calculate the cv (standard
deviation / mean) of the spatial cell distribution.
Statistical analysis
After testing the data for normal distribution and equal
variance, differences between the groups were analyzed
by the unpaired Student’s t-test (SigmaPlot 11.0; Jandel
Corporation, San Rafael, CA, USA). In case of non-
parametric data, a Mann-Whitney rank sum test was used.
All values are expressed as means ± SEM. Statistical signifi-
cance was accepted for a value of p < 0.05.
Additional files
Additional file 1: Figure S1. Cell distribution within SVF- and ad-MVF-
seeded scaffolds. a, b Detection of cell nuclei (arrows) within a SVF- (a) and an
ad-MVF-seeded (b) Integra® scaffold (dotted lines = implant border; green
signals = autofluorescence of the biomaterial). Scale bars: 150 μm. c Cv
of SVF- (white bar, n = 4) and ad-MVF-seeded (black bar, n = 4) Integra®
scaffolds directly after the seeding procedure, as assessed by histology.
Means ± SEM. *p < 0.05 vs. SVF-seeded Integra® scaffolds. (PPTX 849 kb)
Additional file 2: Figure S2. Intravital fluorescence microscopy of
implanted non-seeded scaffolds. a-c Intravital fluorescence microscopy
(blue light epi-illumination with contrast enhancement by 5% FITC-labeled
dextran) of a non-seeded Integra® scaffold on day 14 after implantation into
a full-thickness skin defect within the dorsal skinfold chamber of a C57BL/6
recipient mouse (dotted lines = implant borders; arrows = perfused
blood vessels; b, c = higher magnifications of inserts in a and b). Scale
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bars: a = 2.4 mm; b = 500 μm; c = 125 μm. d-g Perfused ROIs (d, e) and
FMD (f, g) in the border (d, f) and center zones (e, g) of non-seeded
Integra® scaffolds (grey circles, n = 4) on day 0, 3, 6, 10 and 14 after
implantation, as assessed by intravital fluorescence microscopy. Means ±
SEM. (PPTX 651 kb)
Additional file 3: Figure S3. Incorporation, vascularization and
epithelialization of implanted non-seeded scaffolds. a, b HE-stained section
of a non-seeded Integra® scaffold on day 14 after implantation into a
full-thickness skin defect within the dorsal skinfold chamber of a C57BL/6
recipient mouse (broken line = implant; closed frame = center zone of the
implant; b = higher magnification of closed frame in a; arrows = nuclei of
individual cells). Scale bars: a = 260 μm; b = 40 μm. c Total collagen ratio in
the border and center zones of non-seeded Integra® scaffolds (grey
bars, n = 4) on day 14 after implantation, as assessed by histology.
Means ± SEM. d Microvessel density in the border and center zones of
non-seeded Integra® scaffolds (grey bars, n = 4) on day 14 after implantation,
as assessed by immunohistochemistry. Means ± SEM. e Epithelialization of
non-seeded Integra® scaffolds (grey circles, n = 4) on day 0, 3, 6, 10 and
14 after implantation, as assessed by trans-illumination microscopy.
Means ± SEM. (PPTX 1734 kb)
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